Muscular dystrophy damages the body by destroying muscle fibers faster than they can repair themselves, gradually replacing working muscle with scar tissue and fat. The effects extend well beyond the muscles you use to walk and lift. Depending on the type, muscular dystrophy can weaken the heart, compromise breathing, curve the spine, lock joints into fixed positions, and in some cases affect cognitive development.
Why Muscle Fibers Break Down
Healthy muscle cells rely on a protein called dystrophin to survive the stress of contracting. Dystrophin acts like an internal shock absorber, anchoring the inside of a muscle cell to its outer membrane and transmitting the force of contraction safely outward. Without functional dystrophin, the cell membrane tears every time the muscle contracts. Those tiny tears let calcium flood in, triggering inflammation and cell death.
The body tries to repair the damage using specialized stem cells within the muscle. Early on, this works reasonably well, which is why children with Duchenne muscular dystrophy (the most common and severe form) often appear healthy at birth. But the repair cycle can’t keep pace with ongoing destruction. Over months and years, the body fills in dead muscle tissue with collagen and scar tissue, a process called fibrosis. A signaling molecule called TGF-beta, which ramps up after muscle injury, drives collagen production from both muscle cells and surrounding tissue. The result is muscles that feel firm or even enlarged but are progressively weaker because the tissue doing the work is no longer functional muscle.
Which Muscles Weaken First
The pattern of weakness depends on the type of muscular dystrophy, and knowing the pattern helps explain why daily life changes in different ways for different people.
- Duchenne and Becker: Weakness starts in the upper legs and upper arms, making climbing stairs, getting up from the floor, and raising objects overhead difficult first.
- Myotonic dystrophy: The face, neck, hands, and lower legs weaken first, often causing grip problems, foot drop, and difficulty with facial expressions.
- Facioscapulohumeral (FSHD): The face, shoulders, and upper arms are affected earliest, making it hard to raise the arms, whistle, or close the eyes tightly.
- Limb-girdle: Weakness targets the hips and shoulders, similar to Duchenne but typically with a later onset.
- Oculopharyngeal: The eye muscles and throat weaken first, causing drooping eyelids and difficulty swallowing.
- Distal: The feet, hands, and forearms lose strength first, affecting fine motor tasks and balance.
Despite these different starting points, most forms eventually spread to involve larger portions of the body’s voluntary muscles.
How the Heart Is Affected
Dystrophin isn’t only found in skeletal muscle. It also stabilizes heart muscle cells, and its absence makes the heart vulnerable to the same cycle of damage, inflammation, and scarring. The heart gradually enlarges and weakens, a condition called dilated cardiomyopathy, which reduces its ability to pump blood effectively.
In Duchenne muscular dystrophy, the risk of reduced heart function climbs steeply with age: fewer than 5% of boys under 10 show signs of it, but more than 75% of those over 20 do. Cardiac disease is the primary cause of death in over 20% of people with Duchenne. Becker muscular dystrophy, the milder cousin caused by partially functional dystrophin, carries a particularly high cardiac burden. Roughly 70% of people with Becker develop dilated cardiomyopathy, most commonly in their 30s or later.
Myotonic dystrophy type 1 affects the heart differently. About 80% of people with DM1 develop cardiac involvement, but the primary threat is abnormal heart rhythms rather than a weakened pump. The electrical signals that coordinate each heartbeat slow or become erratic, which can cause fainting, palpitations, or in serious cases sudden cardiac arrest. Emery-Dreifuss muscular dystrophy carries a similar risk of progressive heart rhythm problems that can lead to sudden death even when skeletal muscle symptoms are relatively mild.
Breathing and Lung Function
Breathing depends on the diaphragm, a dome-shaped muscle beneath the lungs, and the small muscles between the ribs. When muscular dystrophy weakens these muscles, the lungs can’t expand fully. Each breath draws in less air, and the body gradually struggles to take in enough oxygen and expel enough carbon dioxide.
The decline is usually slow enough that people adapt without realizing how much lung capacity they’ve lost. Early signs include restless sleep, morning headaches, and fatigue that feels out of proportion to activity. Over time, breathing difficulty becomes more obvious during colds or respiratory infections, when even a small amount of mucus can overwhelm weakened cough muscles. In advanced stages, the diaphragm may lose function entirely, requiring a ventilator to assist with breathing, particularly during sleep at first and eventually around the clock.
Children who lose the ability to walk are especially vulnerable to respiratory decline because they also tend to develop scoliosis. A curved spine compresses the chest cavity, physically limiting how much the lungs can expand and compounding the problem caused by muscle weakness alone.
Joint Contractures and Spinal Changes
As certain muscles weaken while opposing muscles remain relatively strong, joints are pulled into fixed, bent positions called contractures. The tendons and connective tissue around the joint shorten permanently, reducing range of motion even further. Contractures commonly affect the ankles, knees, hips, elbows, and wrists, and they can develop even before significant muscle weakness is apparent.
Scoliosis, or curvature of the spine, is most likely in growing children who can no longer walk. Without the trunk muscles needed to hold the spine upright, gravity and uneven muscle pull cause the spine to curve sideways. This isn’t just a posture issue. A severe curve crowds the lungs, makes sitting painful, and complicates positioning in a wheelchair. Bracing and in some cases surgical correction with spinal rods can help maintain trunk alignment and preserve lung space.
Effects on the Brain
Dystrophin isn’t exclusively a muscle protein. The same gene produces at least seven different versions of the protein, several of which are active in the brain during development. In Duchenne muscular dystrophy, the location of the genetic mutation determines which brain versions are lost, and that directly influences cognitive outcomes.
Mutations that knock out only the full-length muscle version of dystrophin tend to leave intelligence in the normal range, with average IQ scores around 90. But mutations that also disrupt the shorter brain-specific versions, particularly those called Dp140 and Dp71, are associated with significantly lower IQ scores (averaging around 70) and a higher risk of intellectual disability. Losing the Dp71 version appears to have the most severe impact: all patients with mutations affecting this form show significant intellectual disability.
Even when IQ falls within the normal range, children with Duchenne have higher rates of attention difficulties, anxiety, and challenges with working memory compared to peers. These are not caused by living with a physical disability. They stem directly from the absence of dystrophin in brain circuits involved in learning and emotional regulation. Recognizing this connection matters because educational support and behavioral strategies can make a meaningful difference when started early.
How Life Expectancy Has Changed
Advances in cardiac care, respiratory support, and corticosteroid treatment have significantly shifted the trajectory for people with muscular dystrophy. For Duchenne, the most well-tracked form, median life expectancy rose from about 18 years for those born before 1970 to 24 years for those born in the 1990s. Because most people with Duchenne born after 2000 are still alive, researchers can’t yet calculate their median survival, but the trend continues upward. Many are now living into their 30s and beyond with proactive heart and lung management.
Becker muscular dystrophy, with its partially functional dystrophin, follows a much slower course. Many people remain ambulatory into their 20s or 30s, though heart failure becomes the central medical concern by middle age. Myotonic dystrophy, facioscapulohumeral, and limb-girdle types vary widely. Some cause only mild limitations over a normal lifespan, while others progress to significant disability depending on the specific genetic mutation involved.
Current Treatment Approaches
There is no cure for muscular dystrophy, but treatment has moved well beyond simply managing symptoms. Corticosteroids remain the standard treatment for Duchenne, slowing muscle loss and helping children walk independently for an additional two to five years on average. Physical therapy and stretching programs help delay contractures and maintain functional movement.
The first gene therapy for Duchenne received FDA approval in recent years. It uses a harmless virus to deliver a miniaturized, functional version of the dystrophin gene directly to muscle cells. Early trials have shown the shortened protein can be produced in treated muscles, with signs of functional improvement. However, the therapy carries risks including immune reactions that can affect the heart, liver, and muscles themselves, and its long-term durability is still being evaluated.
Heart medications that reduce strain on the cardiac muscle are now started early, often before symptoms appear, which has been one of the biggest contributors to improved survival. Nighttime ventilation support, introduced when breathing tests show declining lung capacity, prevents the dangerous buildup of carbon dioxide during sleep and helps preserve energy during the day. Together, these interventions don’t stop the disease but meaningfully slow its impact on the body’s most critical systems.